Voloridge Investment Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-182,059
| Closed | -$2.86M | – | 1406 |
|
|
2024
Q1 | $2.86M | Sell |
182,059
-12,170
| -6% | -$191K | 0.01% | 779 |
|
|
2023
Q4 | $3.13M | Buy |
+194,229
| New | +$3.13M | 0.01% | 722 |
|
|
2023
Q1 | – | Sell |
-233,699
| Closed | -$3.83M | – | 1668 |
|
|
2022
Q4 | $3.83M | Sell |
233,699
-49,649
| -18% | -$814K | 0.02% | 754 |
|
|
2022
Q3 | $5.24M | Sell |
283,348
-72,790
| -20% | -$1.35M | 0.03% | 638 |
|
|
2022
Q2 | $4.68M | Sell |
356,138
-260,735
| -42% | -$3.43M | 0.02% | 705 |
|
|
2022
Q1 | $5.72M | Buy |
616,873
+173,111
| +39% | +$1.6M | 0.03% | 591 |
|
|
2021
Q4 | $4.34M | Buy |
+443,762
| New | +$4.34M | 0.02% | 772 |
|
|
2020
Q1 | – | Sell |
-32,263
| Closed | -$2.01M | – | 1465 |
|
|
2019
Q4 | $2.01M | Buy |
32,263
+3,609
| +13% | +$225K | 0.04% | 489 |
|
|
2019
Q3 | $973K | Buy |
+28,654
| New | +$973K | 0.02% | 648 |
|